ResearchMoz

United States Non-Vascular Stents Market Outlook to 2020

GlobalData
Published Date » 2014-07-14
No. Of Pages » 109
   
 GlobalDatas new report, "United States Non-Vascular Stents Market Outlook to 2020", provides key market data on the United States Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate...
Table of Content

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Non-Vascular Stents Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8

3 Non-Vascular Stents Market, United States 11
3.1 Non-Vascular Stents Market, United States, Revenue ($m), 2005-2013 11
3.2 Non-Vascular Stents Market, United States, Revenue ($m), 2013-2020 13
3.2.1 Biliary Stents Market, United States, Revenue ($m), by Segment, 2005-2013 15
3.2.1.1 Metal Biliary Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 17
3.2.2 Gastrointestinal Stents Market, United States, Revenue ($m), by Segment, 2005-2013 19
3.2.3 Airway Stents Market, United States, Revenue ($m), by Segment, 2005-2013 21
3.2.3.1 Metallic Airway Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 23
3.2.4 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2005-2013 25
3.2.4.1 Prostate Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 27
3.2.4.2 Ureteral Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 29
3.2.4.3 Urethral Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 31
3.2.5 Biliary Stents Market, United States, Revenue ($m), by Segment, 2013-2020 33
3.2.5.1 Metal Biliary Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 35
3.2.6 Gastrointestinal Stents Market, United States, Revenue ($m), by Segment, 2013-2020 37
3.2.7 Airway Stents Market, United States, Revenue ($m), by Segment, 2013-2020 39
3.2.7.1 Metallic Airway Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 41
3.2.8 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2013-2020 43
3.2.8.1 Prostate Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 45
3.2.8.2 Ureteral Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 47
3.2.8.3 Urethral Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 49
3.3 Non-Vascular Stents Market, United States, Volume (Units), 2005-2013 51
3.4 Non-Vascular Stents Market, United States, Volume (Units), 2013-2020 53
3.4.1 Biliary Stents Market, United States, Volume (Units), by Segment, 2005-2013 55
3.4.1.1 Metal Biliary Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 57
3.4.2 Gastrointestinal Stents Market, United States, Volume (Units), by Segment, 2005-2013 59
3.4.3 Airway Stents Market, United States, Volume (Units), by Segment, 2005-2013 61
3.4.3.1 Metallic Airway Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 63
3.4.4 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2005-2013 65
3.4.4.1 Prostate Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 67
3.4.4.2 Ureteral Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 69
3.4.4.3 Urethral Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 71
3.4.5 Biliary Stents Market, United States, Volume (Units), by Segment, 2013-2020 73
3.4.5.1 Metal Biliary Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 75
3.4.6 Gastrointestinal Stents Market, United States, Volume (Units), by Segment, 2013-2020 77
3.4.7 Airway Stents Market, United States, Volume (Units), by Segment, 2013-2020 79
3.4.7.1 Metallic Airway Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 81
3.4.8 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2013-2020 83
3.4.8.1 Prostate Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 85
3.4.8.2 Ureteral Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 87
3.4.8.3 Urethral Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 89
3.5 Non-Vascular Stents Market, United States, Average Price ($), 2005-2020 91
3.6 Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), 2012-2013 95
3.7 Non-Vascular Stents Market, United States, Company Share by Revenue ($m), 2012-2013 96

4 Overview of Key Companies in United States, Non-Vascular Stents Market 98
4.1 Boston Scientific Corporation 98
4.1.1 Company Overview 98
4.2 Cook Group Incorporated 98
4.2.1 Company Overview 98
4.3 C. R. Bard, Inc. 98
4.3.1 Company Overview 98
4.4 Covidien plc 99
4.4.1 Company Overview 99
4.5 Applied Medical Corporation 99
4.5.1 Company Overview 99
4.6 Taewoong Medical Co.,Ltd. 99
4.6.1 Company Overview 99
4.7 Olympus Corporation 100
4.7.1 Company Overview 100
4.8 ConMed Corporation 100
4.8.1 Company Overview 100
4.9 Merit Medical Systems, Inc. 100
4.9.1 Company Overview 100

5 Appendix 101
5.1 Research Methodology 102
5.1.1 Coverage 102
5.1.2 Secondary Research 102
5.1.3 Primary Research 103
5.1.4 Market Modeling and Forecasting 104
5.1.5 Company Share Analysis 107
5.1.6 Distribution Share Analysis 108
5.2 Expert Panel 108
5.3 GlobalData Consulting 109
5.4 Contact Us 109
5.5 Disclaimer 109

List of Tables


Table 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 12
Table 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 14
Table 3: Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 16
Table 4: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 18
Table 5: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 20
Table 6: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 22
Table 7: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 24
Table 8: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 26
Table 9: Prostate Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 28
Table 10: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 30
Table 11: Urethral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 32
Table 12: Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 34
Table 13: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 36
Table 14: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 38
Table 15: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 40
Table 16: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 42
Table 17: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 44
Table 18: Prostate Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 46
Table 19: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 48
Table 20: Urethral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 50
Table 21: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2005-2013 52
Table 22: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2013-2020 54
Table 23: Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 56
Table 24: Metal Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 58
Table 25: Gastrointestinal Stents Market, United States, Volume (Units), Historic, 2005-2013 60
Table 26: Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 62
Table 27: Metallic Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 64
Table 28: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2005-2013 66
Table 29: Prostate Stents Market, United States, Volume (Units), Historic, 2005-2013 68
Table 30: Ureteral Stents Market, United States, Volume (Units), Historic, 2005-2013 70
Table 31: Urethral Stents Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 72
Table 32: Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 74
Table 33: Metal Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 76
Table 34: Gastrointestinal Stents Market, United States, Volume (Units), Forecast, 2013-2020 78
Table 35: Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 80
Table 36: Metallic Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 82
Table 37: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2013-2020 84
Table 38: Prostate Stents Market, United States, Volume (Units), Forecast, 2013-2020 86
Table 39: Ureteral Stents Market, United States, Volume (Units), Forecast, 2013-2020 88
Table 40: Urethral Stents Market, United States, Volume (Units), Forecast, 2013-2020 90
Table 41: Non-Vascular Stents Market, United States, Average Price ($), Historic, 2005-2013 91
Table 42: Non-Vascular Stents Market, United States, Average Price ($), Forecast, 2013-2020 93
Table 43: Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013 95
Table 44: Non-Vascular Stents Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013 97
Table 45: Total Number of Primary Research Participants, General Surgery Market, by Country 104

List of Figures


Figure 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 11
Figure 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 13
Figure 3: Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 15
Figure 4: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 17
Figure 5: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 19
Figure 6: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 21
Figure 7: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 23
Figure 8: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 25
Figure 9: Prostate Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 27
Figure 10: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 29
Figure 11: Urethral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 31
Figure 12: Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 33
Figure 13: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 35
Figure 14: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 37
Figure 15: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 39
Figure 16: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 41
Figure 17: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 43
Figure 18: Prostate Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 45
Figure 19: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 47
Figure 20: Urethral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 49
Figure 21: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2005-2013 51
Figure 22: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2013-2020 53
Figure 23: Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 55
Figure 24: Metal Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 57
Figure 25: Gastrointestinal Stents Market, United States, Volume (Units), Historic, 2005-2013 59
Figure 26: Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 61
Figure 27: Metallic Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 63
Figure 28: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2005-2013 65
Figure 29: Prostate Stents Market, United States, Volume (Units), Historic, 2005-2013 67
Figure 30: Ureteral Stents Market, United States, Volume (Units), Historic, 2005-2013 69
Figure 31: Urethral Stents Market, United States, Volume (Units), Historic, 2005-2013 71
Figure 32: Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 73
Figure 33: Metal Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 75
Figure 34: Gastrointestinal Stents Market, United States, Volume (Units), Forecast, 2013-2020 77
Figure 35: Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 79
Figure 36: Metallic Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 81
Figure 37: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2013-2020 83
Figure 38: Prostate Stents Market, United States, Volume (Units), Forecast, 2013-2020 85
Figure 39: Ureteral Stents Market, United States, Volume (Units), Forecast, 2013-2020 87
Figure 40: Urethral Stents Market, United States, Volume (Units), Forecast, 2013-2020 89
Figure 41: Non-Vascular Stents Market, United States, Company Share (%), 2013 96
Figure 42: GlobalData Epidemiology-Based Forecasting Model 106
Figure 43: GlobalData Capital Equipment-Based Forecasting Model 107
Figure 44: Primary Interviews by Participant Type (%) 108

Upcoming Reports:

Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs. However, these possibilities are opposed by some scientific challenges and unanswered questions.  Some of the major factors driving the market are rising healthcare cost, expensive drugs and the ageing population. The major challenges faced by the...
Global Contrast Media/Contrast Agents Market - Global Industry Analysis, Size, Growth, Share, and Forecast, 2012 - 2018
By - Transparency Market Research
Contrast media or contrast agents provide better images of anatomical structures since they increase the image contrast, thus providing better images of body structures and organs. These agents are helpful in providing better visualization of body structures during several medical procedures such as computed tomography (CT), X-ray, catheterization laboratory (cath lab), and ultrasound and magnetic resonance imaging (MRI). North America accounts for the highest share in global contrast media/ contrast agents market followed by Europe. The reason for North America and Europe...
Biaxially Oriented Polypropylene (BOPP) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Biaxially Oriented Polypropylene (BOPP) is formed when polypropylene films are stretched and extruded in both directions, i.e., across machine direction (AMD) and machine direction (MD). This process of creating biaxial formation increased clarity and strength of the polymer. BOPP is manufactured by two methods: bubble method and tenter method. The properties of BOPP are high tensile strength, high clarity and gloss, excellent water vapor barrier, oil and grease resistant and puncture and flex-crack resistant. The applications of BOPP include packaging of food products, labeling, pressure...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...